Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
09/2011
09/20/2011US8021874 Very long chain polyunsaturated fatty acids, methods of production, and uses
09/20/2011US8021869 Method of cell storage in a delivery system comprising a fibrous matrix
09/20/2011US8021868 Lactobacillus mixture comprising secreted cytokines for use in treatment and prevention of allergies
09/20/2011US8021866 Therapeutic use of ADPase enhanced apyrases
09/20/2011US8021865 Thermophilic micro-organisms for ethanol production
09/20/2011US8021861 Pathogenic Escherichia coli associated protein
09/20/2011US8021857 Glyphosate-N-acetyltransferase (GAT) genes
09/20/2011US8021838 Transcriptional regulation of target genes
09/20/2011US8021832 Proteins expressed by Mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines
09/20/2011US8021673 Proteins with repetitive Bacterial-Ig-like (Big) domains present in Leptospira species
09/20/2011US8021671 Pro-apoptotic bacterial vaccines to enhance cellular immune responses
09/20/2011US8021656 Probiotics for gut neuromuscular functions
09/20/2011US8021655 Methods of feeding ruminants
09/20/2011US8021653 Shuttle vector for Bifidobacterium and Escherichia coli
09/20/2011CA2376485C Recombinant anti-cd40 antibody and uses thereof
09/20/2011CA2369848C Human endogenous retrovirus in breast cancer
09/20/2011CA2360758C 1-deoxy-d-xylulose-5-phosphate reductoisomerases, and methods of use
09/20/2011CA2356009C Vascular endothelial growth factor-x
09/20/2011CA2329137C Novel tumor antigen useful in diagnosis and therapy of prostrate and colon cancer
09/20/2011CA2278208C Cell separation method
09/20/2011CA2217522C Isolated frpb nucleic acid molecule and vaccine
09/15/2011WO2011113003A1 Viable gram negative bacteria lacking outer membrane agonists of tlr4/md-2
09/15/2011WO2011112948A1 Yeast strains and their uses in the production of lipids
09/15/2011WO2011112781A2 Enterobacter sp. 638 and methods of use thereof
09/15/2011WO2011112627A1 Methods, biological oils, biofuels, units, and organisms related to use in compression engines
09/15/2011WO2011111920A1 Composition comprising rice bran protein hydrolysate for use in culturing of microorganisms
09/15/2011WO2011111838A1 Novel lipoxygenases derived from lemna paucicostata
09/15/2011WO2011111836A1 Mutated alkaline celluase
09/15/2011WO2011111740A1 Method of separating cells and separation apparatus
09/15/2011WO2011111734A1 Lactic acid bacterium-containing preparation
09/15/2011WO2011111638A1 Highly productive isopropyl alcohol-producing bacterium
09/15/2011WO2011111393A1 Fc binding protein and method for producing same
09/15/2011WO2011111392A1 Hjurp peptides and vaccines including the same
09/15/2011WO2011110926A1 Food product comprising probiotic bacteria coated with a coating of vegetable origin
09/15/2011WO2011110884A1 Lactic acid bacteria for coeliac disease
09/15/2011WO2011110758A1 Treatment of plants against oomycete infection
09/15/2011WO2011110731A2 Method and apparatus for accelerating biotechnical reaction and production
09/15/2011WO2011110073A1 Isolation and purification method of cell culture mixture
09/15/2011WO2011056886A3 Method and composition for generating programmed cell death resistant algal cells
09/15/2011WO2011041122A3 Biocontrol of storage maladies of potatoes by bacterial antagonists produced in co-culture
09/15/2011WO2011025310A3 Attenuated salmonella variant strain resulting from the genetic transformation of adhesin from pathogenic pig escherichia coli and a vaccine composition comprising the same for preventing and treating pathogenic colibacillosis and salmonellosis in pigs
09/15/2011US20110225682 Polynucleotides encoding caryophyllene synthase and uses thereof
09/15/2011US20110225674 Transformed plants or algae with highly expressed chloroplast protein BPG2
09/15/2011US20110225663 Method for producing eukaryotic organisms with enhanced pathogen resistance and/or resistance to stress and eukaryotic transgenic organisms with enhanced pathogen resistance and/or resistance to stress
09/15/2011US20110224420 Solid support
09/15/2011US20110224153 Asthma Associated Factors as Targets for Treating Atopic Allergies Including Asthma and Related Disorders
09/15/2011US20110224102 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
09/15/2011US20110224099 Bead bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries
09/15/2011US20110224097 Viable gram negative bacteria lacking outer membrane agonists of tlr4/md-2
09/15/2011US20110224095 Expression of functional human olfactory cyclic nucleotide gated (CNG) channel in recombinant host cells and use thereof in cell based assays to identify smell modulators
09/15/2011US20110223671 Methods for using positively and negatively selectable genes in a filamentous fungal cell
09/15/2011US20110223657 Trp/his exchange and kynurenin induced trp transport
09/15/2011US20110223649 Recombinant cell transformed by an arabidopsis thaliana atpase athma1 sequence
09/15/2011US20110223641 Microbial engineering for the production of fatty acids and fatty acid derivatives
09/15/2011US20110223640 Improved statin production
09/15/2011US20110223637 Methods and organisms for utilizing synthesis gas or other gaseous carbon sources and methanol
09/15/2011US20110223636 Fluorescent protein and chromoprotein
09/15/2011US20110223609 Gene defects and mutant ALK kinase in human solid tumors
09/15/2011US20110223288 Method for producing alanine-rich yeast
09/15/2011US20110223287 Method for producing yeast with high glutamic acid content
09/15/2011US20110223284 Compositions and Methods for Producing Fermentation Products and Residuals
09/15/2011US20110223188 Targeted costimulatory polypeptides and methods of use to treat cancer
09/15/2011US20110223186 Clostridium toxin, and process for the preparation of immunogenic composition
09/15/2011US20110223185 Chimeric hepatitis c virus antigens for eliciting an immune response
09/15/2011US20110223165 Humanized C-Kit Antibody
09/15/2011US20110223155 Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases
09/15/2011US20110223147 Lysosomal targeting peptides and uses thereof
09/15/2011US20110223117 Alpha-glucanase and oral care composition containing the same
09/15/2011US20110223107 Antibodies that specifically block the biological activity of a tumor antigen
09/15/2011US20110220570 Heavy metal remediation system
09/15/2011CA2827352A1 Method and apparatus for accelerating biotechnical reaction and production
09/15/2011CA2792933A1 Enterobacter sp. 638 and methods of use thereof
09/15/2011CA2792910A1 Hjurp peptides and vaccines including the same
09/15/2011CA2792904A1 Systems and methods for positioning flexible floating photobioreactors
09/15/2011CA2792773A1 Treatment of plants against oomycete infection
09/15/2011CA2792546A1 Highly productive isopropyl alcohol-producing bacterium
09/15/2011CA2792494A1 Yeast strains and their uses in the production of lipids
09/15/2011CA2791986A1 Methods, biological oils, biofuels, units, and organisms related to use in compression engines
09/15/2011CA2791697A1 Viable gram negative bacteria lacking outer membrane agonists of tlr4/md-2
09/14/2011EP2365090A1 Method for enhancing production of isoprenoid compounds
09/14/2011EP2365089A1 Method of engineering a cytidine monophosphate-sialic acid synthetic pathway in fungi and yeast
09/14/2011EP2365088A2 Polyhydroxyalkanoate production by coenzyme a-dependent aldehyde dehydrogenase pathways
09/14/2011EP2365085A1 Growth hormone fusion protein
09/14/2011EP2365083A1 Lactic acid bacterial starter cultures and compositions thereof
09/14/2011EP2365081A2 13 Transmembrane protein expressed in prostate cancer
09/14/2011EP2365076A1 Artificial ubiquitous chromatin opening elements (ucoe)
09/14/2011EP2365074A1 Coenzyme-linked glucose dehydrogenase and polynucleotide encoding the same
09/14/2011EP2365073A1 Coenzyme-linked glucose dehydrogenase and polynucleotide encoding the same
09/14/2011EP2365064A1 Phytase variants
09/14/2011EP2364999A2 Dual-specific ligand and its use
09/14/2011EP2364997A2 Polypeptide variants with altered effector function
09/14/2011EP2364769A1 Devices and methods for biomaterial production
09/14/2011EP2364357A1 Mycobacteria culture medium and method including mycobacteria of mycobacterium tuberculosis complex
09/14/2011EP2364156A2 Modified protozoan expressing at least two variable surface proteins (vsp), a vaccine comprising it and procedures, uses, and methods thereof
09/14/2011EP1920046B1 Method of ethanol production by aid of liquid yeast
09/14/2011EP1882737B1 Process for production of l-serine derivative and enzyme used in the process
09/14/2011EP1776451B1 Method for the production of l-amino acids using strains from the enterobacteraceae family
09/14/2011EP1694854B1 Novel carotenoids ketolases
09/14/2011EP1349955B1 Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia
09/14/2011EP1027440B2 Inhibitor protein of the wnt signal pathway